Xiamen Amoytop Biotech Co Ltd (688278) — Cash Flow Reinvestment Rate
Xiamen Amoytop Biotech Co Ltd (688278) has a Cash Flow Reinvestment Rate of 0.37x as of September 2023, reinvesting CN¥122.64 Million (capex CN¥43.00 Million plus investments CN¥-79.64 Million) from operating cash flow of CN¥332.29 Million. Check Xiamen Amoytop Biotech Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiamen Amoytop Biotech Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Xiamen Amoytop Biotech Co Ltd across 8 annual periods. Explore Xiamen Amoytop Biotech Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Xiamen Amoytop Biotech Co Ltd. For live market cap and broader valuation context, see 688278 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.30x | CN¥559.97 Million | CN¥430.63 Million | CN¥251.35 Million | ▲ +38.8% |
| 2023 | 0.94x | CN¥479.66 Million | CN¥512.10 Million | CN¥244.48 Million | ▼ -33.1% |
| 2022 | 1.40x | CN¥508.57 Million | CN¥363.16 Million | CN¥219.17 Million | ▲ +22.0% |
| 2021 | 1.15x | CN¥269.58 Million | CN¥234.78 Million | CN¥190.93 Million | ▼ -72.2% |
| 2020 | 4.14x | CN¥382.99 Million | CN¥92.61 Million | CN¥118.81 Million | ▲ +65.0% |
| 2019 | 2.51x | CN¥309.00 Million | CN¥123.30 Million | CN¥44.83 Million | ▼ -19.9% |
| 2018 | 3.13x | CN¥278.78 Million | CN¥89.15 Million | CN¥14.60 Million | ▼ -23.3% |
| 2016 | 4.08x | CN¥172.97 Million | CN¥42.43 Million | CN¥87.03 Million | — |